VIR
Vir Biotechnology, Inc.
$9.12
-1.62%
2026-05-08
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Key Fundamentals
Forward P/E
-4.00
EPS (TTM)
$-3.13
ROE
-47.7%
Revenue Growth (YoY)
417.8%
Profit Margin
0.0%
Debt/Equity
10.66
Price/Book
1.67
Beta
1.69
Market Cap
$1.55B
Avg Volume (10D)
1.5M
Recent Breakout Signals
No recent breakout signals detected for VIR.
Recent Price Range (60 Days)
60D High
$11.50
60D Low
$7.10
Avg Volume
3.5M
Latest Close
$9.12
Get breakout alerts for VIR
Sign up for Breakout Scanner to receive daily notifications when VIR triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Vir Biotechnology, Inc. (VIR) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors VIR daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. VIR operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.